Experience with neoral cyclosporine through the oral route in liver transplantation

Transplant Proc. 1998 Jun;30(4):1432-4. doi: 10.1016/s0041-1345(98)00303-0.
No abstract available

Publication types

  • Clinical Trial

MeSH terms

  • Administration, Oral
  • Cyclosporine / administration & dosage
  • Cyclosporine / adverse effects
  • Cyclosporine / therapeutic use*
  • Female
  • Follow-Up Studies
  • Graft Rejection / drug therapy
  • Graft Rejection / epidemiology*
  • Graft Rejection / pathology
  • Graft Survival
  • Humans
  • Immunosuppressive Agents / administration & dosage
  • Immunosuppressive Agents / adverse effects
  • Immunosuppressive Agents / therapeutic use*
  • Liver Transplantation / immunology*
  • Liver Transplantation / mortality
  • Liver Transplantation / physiology
  • Male
  • Methylprednisolone / therapeutic use
  • Middle Aged
  • Prospective Studies
  • Reoperation
  • Survival Rate
  • Tacrolimus / therapeutic use
  • Time Factors

Substances

  • Immunosuppressive Agents
  • Cyclosporine
  • Tacrolimus
  • Methylprednisolone